Skip to main content
Medical information Clinical review pending

Genetic Testing

BSCL2 Gene Lipodystrophy Generalized Type 2 Genetic Test

Genetic test to identify mutations in the BSCL2 gene associated with generalized lipodystrophy type 2, a metabolic disorder affecting fat distribution. Helps in diagnosis and management.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Blood sample (EDTA tube), Extracted DNA, or One drop of blood on an FTA card.
Results
Confirm with the laboratory before booking.
Preparation
Clinical history of the patient, including family history of lipodystrophy or related metabolic disorders, is required. A genetic counseling session may be recommended prior to testing.
Test priceKSh 40,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the BSCL2 Gene Lipodystrophy Generalized Type 2 Genetic Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Individuals with a family history of lipodystrophy.
  • ✓Patients presenting with symptoms suggestive of lipodystrophy (e.g., abnormal fat distribution, insulin resistance).
  • ✓Diagnosis confirmation in suspected cases of generalized lipodystrophy type 2.
  • ✓Genetic counseling for individuals with metabolic disorders.
  • ✓Family member screening in affected families.
02

In plain language

What this test helps you understand

Identifies mutations in the BSCL2 gene associated with generalized lipodystrophy type 2, aiding in diagnosis, prognosis, and management of this metabolic disorder.
The BSCL2 Gene Lipodystrophy Generalized Type 2 NGS Genetic DNA Test is a diagnostic tool used to identify genetic mutations linked to lipodystrophy. Lipodystrophy is a metabolic disorder characterized by abnormal or deficient fat tissue. This test focuses specifically on the BSCL2 gene, mutations in which are known to cause generalized lipodystrophy type 2. Understanding these genetic factors is important for managing the condition and potential health complications.

This test utilizes Next Generation Sequencing (NGS) technology to analyze the BSCL2 gene for variations. It helps determine if a person carries a mutation associated with this specific type of lipodystrophy.

Individuals with a family history of lipodystrophy, those showing symptoms like abnormal fat distribution, insulin resistance, or metabolic syndrome, or those seeking genetic counseling for metabolic conditions may benefit from this test.

Results can provide insights into genetic predispositions, enabling personalized management strategies and early intervention. A genetic counselor can help interpret the results and discuss their implications for personal health and family planning.

Confirm with the laboratory before booking for specific details regarding sample collection, preparation, and turnaround time.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationClinical history of the patient, including family history of lipodystrophy or related metabolic disorders, is required. A genetic counseling session may be recommended prior to testing.
SampleBlood sample (EDTA tube), Extracted DNA, or One drop of blood on an FTA card.
MethodologyNext Generation Sequencing (NGS) is used to analyze the BSCL2 gene for pathogenic variants.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test specifically analyzes the BSCL2 gene. It will not detect mutations in other genes associated with lipodystrophy or other metabolic disorders. Results must be interpreted in the context of clinical findings and family history. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

Lipodystrophy is a group of metabolic disorders characterized by the loss of fat tissue (partial or generalized) or abnormal fat distribution.
The BSCL2 gene provides instructions for making a protein involved in the metabolism of fats (lipids) within cells.
This test is recommended for individuals with symptoms of lipodystrophy, a family history of the condition, or those seeking genetic clarification for metabolic issues.
Results indicate the presence or absence of specific mutations in the BSCL2 gene. A genetic counselor can help explain the findings and their implications.
Genetic counseling is highly recommended before and after testing to understand the test's implications, interpret results, and discuss family planning.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp